交易中 06-25 11:32:39 美东时间
-0.007
-1.70%
生物技术公司Immutep Limited(NASDAQ: IMMP)正面临证券欺诈集体诉讼。此前该公司宣布,其针对一线非小细胞肺癌的关键三期临床试验TA...
06-11 03:24
Immutep Ltd ( ($AU:IMM) ) has shared an announcement. Immutep Ltd has disclosed...
06-09 16:09
First-in-human Phase I study met its primary endpoint, demonstrating favourable safety and tolerability in healthy volunteers in the single ascending dose part of the studyPhase I data demonstrate statistically
06-04 20:05
Immutep Limited announced results from a systematic evaluation of 5 clinical trials of eftilagimod alfa (efti) in combination with standard-of-care (SOC) therapies in late-stage cancer patients. Treatment with 30 mg subcutaneous efti plus SOC led to a significant increase in circulating absolute lymphocyte count (ALC), associated with improved clinical outcomes, including a median overall survival (OS) improvement of +7.7 months in ALC responders...
05-28 12:00
Immutep(IMMP)told investors its lung cancer treatment could become ...
05-22 02:54
ImmutepLimited (IMMP) said its lung cancer treatment could change everyth...
05-16 02:38
Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), advises that it has received a written notification from The Nasdaq Stock Market LLC (Nasdaq) regarding non-compliance with the Nasdaq minimum bid
04-30 20:06
巨龙在线涨-32.30%;奈飞涨-9.10%;中国循环能源涨-7.52%
04-17 08:10